Log inStart free trialBook a demo
Log inStart free trial
Media Database
>
Courtney Flaherty

Courtney Flaherty

Assistant Editor at OncologyLive

Contact this person
Email address
c*****@*******.comGet email address
Influence score
34
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Health & Medicine

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

onclive.com

FDA Approval of Lurbinectedin/Atezolizumab As First-Line Maintenance Expands Limited Post-Inducti...

FDA Approval of Lurbinectedin/Atezolizumab As First-Line Maintenance Expands Limited Post-Induction Arsenal for ES-SCLC
17 days ago
onclive.com

FDA Grants Fast Track Designation to DPTX3186 for Gastric Cancer

FDA Grants Fast Track Designation to DPTX3186 for Gastric Cancer
17 days ago
onclive.com

FDA Approves New Pertuzumab Biosimilar for Select HER2+ Breast Canc...

FDA Approves New Pertuzumab Biosimilar for Select HER2+ Breast Cancer Subtypes
22 days ago
onclive.com

Early Activity With DB-1305/BNT325 Signals Potential Expansion of T...

Early Activity With DB-1305/BNT325 Signals Potential Expansion of TROP-2 ADCs in Pretreated Metastatic TNBC
24 days ago
onclive.com

First-Line Sacituzumab Govitecan After Endocrine Therapy Fails to I...

First-Line Sacituzumab Govitecan After Endocrine Therapy Fails to Improve PFS in HR+/HER2-Negative Breast Cancer
28 days ago
onclive.com

Vispa-Cel Shows Comparable Efficacy, Durability to Autologous CAR T...

Vispa-Cel Shows Comparable Efficacy, Durability to Autologous CAR T-Cell Therapy in R/R B-Cell NHL
about 1 month ago
onclive.com

Toripalimab Becomes First Approved Immunotherapy for Recurrent Unre...

Toripalimab Becomes First Approved Immunotherapy for Recurrent Unresectable/Metastatic NPC in Canada
about 1 month ago
onclive.com

Real-World Evidence Complements Randomized Clinical Trial Data in C...

Real-World Evidence Complements Randomized Clinical Trial Data in Colorectal Cancer
about 2 months ago
onclive.com

OncLive’s September EMA Regulatory Recap: Key EU Approvals in Oncology

OncLive’s September EMA Regulatory Recap: Key EU Approvals in Oncology
2 months ago
onclive.com

Is AI Augmentation Driving Smarter, Better Cancer Care?

Is AI Augmentation Driving Smarter, Better Cancer Care?
2 months ago
onclive.com

FDA Grants Fast Track Designation to ETX-636 for PIK3CA-Mutant, HR+...

FDA Grants Fast Track Designation to ETX-636 for PIK3CA-Mutant, HR+/HER2-Negative Breast Cancer
2 months ago